tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HUMA Stock Latest News

Humacyte announces data from analysis of charges for extremity arterial injury
The FlyHumacyte announces data from analysis of charges for extremity arterial injury
10d ago
HUMA
Humacyte announces planned MAA for Symvess in Israel
PremiumThe Fly
Humacyte announces planned MAA for Symvess in Israel
13d ago
HUMA
Humacyte announces long-term safety, efficacy results of Symvess
PremiumThe Fly
Humacyte announces long-term safety, efficacy results of Symvess
27d ago
HUMA
Humacyte Enters Sales Agreement with TD Securities
PremiumCompany Announcements
Humacyte Enters Sales Agreement with TD Securities
1M ago
8K
HUMA
Humacyte announces credit facility up to $77.5M
PremiumThe Fly
Humacyte announces credit facility up to $77.5M
1M ago
HUMA
Humacyte Secures $77.5 Million Loan Facility
PremiumCompany AnnouncementsHumacyte Secures $77.5 Million Loan Facility
1M ago
8K
HUMA
Humacyte Terminates Revenue Interest Agreement
Premium
Company Announcements
Humacyte Terminates Revenue Interest Agreement
1M ago
8K
HUMA
Buy Rating on Humacyte Driven by Promising Clinical Data and Strong Growth Prospects
Premium
Ratings
Buy Rating on Humacyte Driven by Promising Clinical Data and Strong Growth Prospects
2M ago
HUMA
Humacyte Ends Sale Agreement with Jefferies LLC
PremiumCompany Announcements
Humacyte Ends Sale Agreement with Jefferies LLC
2M ago
8K
HUMA
Humacyte’s Promising Growth in Vascular Therapy Market Justifies Buy Rating
PremiumRatings
Humacyte’s Promising Growth in Vascular Therapy Market Justifies Buy Rating
2M ago
HUMA
Humacyte announces presentations at VEITHsymposium on ATEV results
PremiumThe Fly
Humacyte announces presentations at VEITHsymposium on ATEV results
2M ago
HUMA
Humacyte price target lowered to $11 from $14 at Benchmark
PremiumThe Fly
Humacyte price target lowered to $11 from $14 at Benchmark
2M ago
HUMA
Positive Growth Prospects and Financial Stability Drive Buy Rating for Humacyte
PremiumRatingsPositive Growth Prospects and Financial Stability Drive Buy Rating for Humacyte
2M ago
HUMA
Humacyte Reports Q3 2025 Financial Results and Pipeline Progress
Premium
Company Announcements
Humacyte Reports Q3 2025 Financial Results and Pipeline Progress
2M ago
HUMA
Humacyte’s Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Humacyte’s Earnings Call Highlights Growth and Challenges
2M ago
HUMA
Humacyte’s Promising Growth and Strategic Collaborations Earn a Buy Rating
PremiumRatings
Humacyte’s Promising Growth and Strategic Collaborations Earn a Buy Rating
2M ago
HUMA
Humacyte reports Q3 EPS (11c), consensus (15c)
PremiumThe Fly
Humacyte reports Q3 EPS (11c), consensus (15c)
2M ago
HUMA
Humacyte announces presentation of two-year results from V007 Phase 3 trial
PremiumThe Fly
Humacyte announces presentation of two-year results from V007 Phase 3 trial
2M ago
HUMA
HUMA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
HUMA Upcoming Earnings Report: What to Expect?
2M ago
HUMA
Humacyte announces publication of new data on Symvess
PremiumThe FlyHumacyte announces publication of new data on Symvess
3M ago
HUMA
Humacyte’s Phase 3 Trial: A New Era for Renal Disease Treatment?
Premium
Company Announcements
Humacyte’s Phase 3 Trial: A New Era for Renal Disease Treatment?
3M ago
HUMA
Humacyte price target lowered to $6 from $7 at BTIG
Premium
The Fly
Humacyte price target lowered to $6 from $7 at BTIG
3M ago
HUMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >